UNIVERSITE JOSEPH FOURIER;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
发明人:
XAVIER LEVERVE,NELLIE TALEUX,ROLAND FAVIER
申请号：
BRPI0811636
公开号：
BRPI0811636A2
申请日:
2008.05.16
申请国别(地区):
BR
年份:
2014
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3',5',3-triiodothyronine (rT3), a rT3 derived hormone, or a precursor of rT3, such as T4 in association with a molecule susceptible to promote the formation of rT3, in association with a pharmaceutically acceptable vehicle.
